[go: up one dir, main page]

WO2002038121A1 - Composition cosmetique pour le traitement, le soin ou la protection de la peau - Google Patents

Composition cosmetique pour le traitement, le soin ou la protection de la peau Download PDF

Info

Publication number
WO2002038121A1
WO2002038121A1 PCT/EP2001/012672 EP0112672W WO0238121A1 WO 2002038121 A1 WO2002038121 A1 WO 2002038121A1 EP 0112672 W EP0112672 W EP 0112672W WO 0238121 A1 WO0238121 A1 WO 0238121A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
acid
composition according
composition
antarctica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/012672
Other languages
German (de)
English (en)
Inventor
Thomas Gerke
Kirsten Hoyer
Ulf Karsten
Oliver Nixdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to AU2002224822A priority Critical patent/AU2002224822A1/en
Publication of WO2002038121A1 publication Critical patent/WO2002038121A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella

Definitions

  • UV-A light characteristic wavelength range from 315 to 400 nm
  • typical sunscreens often pass very easily, since these sunscreens often only contain the UV-B- that is the main cause of sunburn. Filter out light effectively. This explains in particular the need for novel substances that absorb in the area of UV-A light.
  • green algae there are substances with suitable absorption spectra. It is known (Post and Larkum (1993), Aquat. Bot., 45, pp. 231-243) that the methanolic extract from Prasiola crispa ssp. antarctica shows an absorption band at 325 nm. It is probably a mycosporin-like amino acid (MAA).
  • MAA mycosporin-like amino acid
  • Another object of the present invention is the use of this UV-absorbing substance or a derivative thereof in cosmetic preparations.
  • polyglycerol esters e.g. Polyglycerol polyricinoleate, polyglycerol poly-12-hydroxystearate or polyglycerol dimerate. Mixtures of compounds from several of these classes of substances are also suitable;
  • UV light protection filters can be added to the composition according to the invention.
  • the further UV light protection filters that can be added to the cosmetic composition are preferably soluble compounds or insoluble pigments or mixtures thereof.
  • UV light protection filters are understood to mean organic substances which are able to absorb ultraviolet rays and release the absorbed energy in the form of longer-wave radiation, for example heat.
  • the organic substances can be oil-soluble or water-soluble.
  • benzoylmethane such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl
  • benzoylmethane such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl
  • typical UV-A filters -4'-methoxydibenzoylmethane or 1-phenyl-3- (4 ' ⁇ isopropylphenyl) propane-1,3-dione.
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • the cosmetic composition can also contain, among other things, caring components such as oils, waxes, fats, lipid-replenishing substances, thickeners, emulsifiers and fragrances.
  • caring components such as oils, waxes, fats, lipid-replenishing substances, thickeners, emulsifiers and fragrances.
  • a high proportion of nourishing substances is particularly advantageous for topical prophylactic or cosmetic treatment of the skin. It is particularly advantageous if, in addition to the animal and vegetable fats and oils, which in many cases also have a care effect, the composition also contains further care components.
  • the group of nourishing active ingredients that can be used includes, for example: fatty alcohols with 8 - 22 carbon atoms, in particular fatty alcohols from natural fatty acids; animal and vegetable protein hydrolyzates, in particular elastin, collagen, keratin, milk protein, soy protein, silk protein, oat protein, pea protein, almond protein and wheat protein hydrolyzates; Vitamins and vitamin precursors, especially those of vitamin groups A and B; Mono-, di- and oligosaccharides; Plant extracts; Honey extracts; ceramides; phospholipids; Petroleum jelly, paraffin and silicone oils; Fatty acid and fatty alcohol esters, especially the monoesters of fatty acids with alcohols with 3 to 24 carbon atoms.
  • the vitamins, provitamins or vitamin precursors to be used preferably in the composition according to the invention include, among others:
  • the 2-furanone derivative which is extremely preferred according to the invention is pantolactone (dihydro-3-hydroxy-4,4-dimethyl-2 (3H) - furanone), where in formula (I) R 1 is a hydroxyl group, R 2 is a hydrogen atom, R 3 and R 4 represent a methyl group and R 5 and R 6 represent a hydrogen atom.
  • the stereoisomer (R) -pantolactone is formed when pantothenic acid is broken down.
  • Vitamin B 6 which does not mean a uniform substance, but rather the derivatives of 5-hydroxymethyl-2-methylpyridin-3-ol known under the trivial names pyridoxine, pyridoxamine and pyridoxal. Vitamin B 6 is contained in the agents according to the invention preferably in amounts of 0.0001 to 1.0% by weight, in particular in amounts of 0.001 to 0.01% by weight.
  • topical preparations for example aqueous and aqueous / alcoholic solutions, aqueous gels, sprays, foams, foam aerosols, ointments, emulsions of the O / W or W / O type or microemulsions, can be prepared in a simple manner from the extracts mentioned ,
  • the composition contains at least one mycosporin-like amino acid (MAA).
  • MAA mycosporin-like amino acid
  • Prasiola crispa ssp. antarctica contains traces of mycosporin-glycine and a large amount of a structurally not yet elucidated UV-absorbing substance, which shows an absorption maximum at 324 nm and which is determined by HPLC analysis (5 vol.% aqueous methanol, 0.1 vol. % Acetic acid; flow rate: 0.7 ml min "1 ; Phenomenex Sphereclone RP-8 column, 5 ⁇ m, 250 x 4 mm ID) is available with a retention time of 3.4 min.
  • HPLC analysis 5 vol.% aqueous methanol, 0.1 vol. % Acetic acid; flow rate: 0.7 ml min "1 ; Phenomenex Sphereclone RP-8 column, 5 ⁇ m, 250 x 4 mm ID
  • the structurally as yet unidentified UV-absorbing substance is also a mycosporin-like amino acid.
  • composition according to the invention preferably contains 0.01 to 10% by weight of the extract, based on the dry mass of the extract. Contents of 0.05 to 1% by weight, in particular 0.1 to 0.5% by weight, based on the dry mass of the extract, are particularly preferred.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition cosmétique pour le traitement, le soin ou la protection de la peau, comprenant un support et caractérisée en ce qu'elle contient un extrait de l'algue verte <i>Prasiola crispa ssp. antarctica</i>.
PCT/EP2001/012672 2000-11-09 2001-11-02 Composition cosmetique pour le traitement, le soin ou la protection de la peau Ceased WO2002038121A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002224822A AU2002224822A1 (en) 2000-11-09 2001-11-02 Cosmetic skin treatment, care or protection composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10055558A DE10055558A1 (de) 2000-11-09 2000-11-09 Kosmetische Zusammensetzung zur Behandlung, zur Pflege oder zum Schutz der Haut
DE10055558.6 2000-11-09

Publications (1)

Publication Number Publication Date
WO2002038121A1 true WO2002038121A1 (fr) 2002-05-16

Family

ID=7662703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/012672 Ceased WO2002038121A1 (fr) 2000-11-09 2001-11-02 Composition cosmetique pour le traitement, le soin ou la protection de la peau

Country Status (3)

Country Link
AU (1) AU2002224822A1 (fr)
DE (1) DE10055558A1 (fr)
WO (1) WO2002038121A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004105722A1 (fr) * 2003-05-30 2004-12-09 Gianfranco De Paoli Ambrosi Formulation servant a realiser une exfoliation chimique
CN104352554A (zh) * 2014-10-21 2015-02-18 河南牧翔动物药业有限公司 一种复方头孢喹肟抗菌药物
CN104352566A (zh) * 2014-10-21 2015-02-18 河南牧翔动物药业有限公司 一种水包油型复方金霉素纳米乳
CN104474164A (zh) * 2014-11-21 2015-04-01 范影 一种治疗阴虚阳亢型神经衰弱的小验方

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259966A1 (de) * 2002-12-15 2004-07-08 Henkel Kgaa Kosmetische oder pharmazeutische Zubereitung zur Verbesserung der Sauerstoffaufnahme bei Menschen oder Tieren
CH701253A1 (de) 2009-06-12 2010-12-15 Mibelle Ag Verwendung eines Extraktes aus Schneealgen in kosmetischen oder dermatologischen Formulierungen.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674126A1 (fr) * 1991-03-19 1992-09-25 Secma Utilisation d'algues rouges calcaires pour la preparation de compositions cosmetiques.
WO2000024369A1 (fr) * 1998-10-23 2000-05-04 Nouvab Inc Composition de protection contre le rayonnement solaire

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643365C2 (de) * 1996-10-09 1998-08-20 Holger Wohner Protein- und vitaminhaltige Kosmetikzusammensetzung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674126A1 (fr) * 1991-03-19 1992-09-25 Secma Utilisation d'algues rouges calcaires pour la preparation de compositions cosmetiques.
WO2000024369A1 (fr) * 1998-10-23 2000-05-04 Nouvab Inc Composition de protection contre le rayonnement solaire

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COCKELL C., KNOWLAND J.: "Ultraviolet radiation screening compounds", BIOLOGICAL REVIEWS OF THE CAMBRIDGE PHILOSOPHICAL SOCIETY, 1999, United Kingdom, pages 311 - 345, XP002196313, Retrieved from the Internet <URL:http://www.botany.hawaii.edu/Bot482/Biol%20Rev%20UV%20abs%20compounds.pdf> [retrieved on 20020415] *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004105722A1 (fr) * 2003-05-30 2004-12-09 Gianfranco De Paoli Ambrosi Formulation servant a realiser une exfoliation chimique
HRP20050972B1 (hr) * 2003-05-30 2013-09-30 Gianfranco De Paoli Ambrosi Formulacija za kemijsko lupljenje (piling)
CN104352554A (zh) * 2014-10-21 2015-02-18 河南牧翔动物药业有限公司 一种复方头孢喹肟抗菌药物
CN104352566A (zh) * 2014-10-21 2015-02-18 河南牧翔动物药业有限公司 一种水包油型复方金霉素纳米乳
CN104474164A (zh) * 2014-11-21 2015-04-01 范影 一种治疗阴虚阳亢型神经衰弱的小验方

Also Published As

Publication number Publication date
AU2002224822A1 (en) 2002-05-21
DE10055558A1 (de) 2002-06-06

Similar Documents

Publication Publication Date Title
EP0945128B1 (fr) Utilisation de flavones, flavanones, ou de flavonoides pour la protection de l&#39;acide ascorbique et/ou de liaisons de type ascorbyle contre l&#39;oxydation
EP1187598B1 (fr) Melanges de micropigments
DE19933466A1 (de) Verwendung von Ectoinen als Antioxidantien oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
DE4444238A1 (de) Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
WO2008025755A1 (fr) utilisation d&#39;hÉTÉrocycles contenant de l&#39;azote dans les cosmÉtiques dermatologiques
EP1068866A2 (fr) Utilisation de mélanges de pigments pour empêcher le bronzage et pour éclaircir la peau et les cheveux
WO2001062223A2 (fr) Preparations cosmetiques contenant des extraits vegetaux
DE19651478A1 (de) Lichtschutzzubereitungen mit einem Gehalt an oberflächenaktiven Mono- bzw. Oligoglycerylverbindungen, wasselöslichen UV-Filtersubstanzen und ggf. anorganischen Mikropigmenten
EP0726273A1 (fr) Tocophénylglycosides, leur préparation et utilisation comme tensides, comme antioxidants et comme prophylactiques pour modification des cellules dans préparations cosmétiques et pharmaceutiques
EP2144595A1 (fr) Agent de protection contre le rayonnement uv à base de systèmes mixtes minéraux-organiques
WO2004111136A1 (fr) Poudre d&#39;oxyde de zinc iii nanoparticulaire pouvant être redispersée
DE19545789C2 (de) Verwendung von Isoalkansäuren
DE10062401A1 (de) Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
WO2002038121A1 (fr) Composition cosmetique pour le traitement, le soin ou la protection de la peau
DE19723732B4 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Monocacylestern des Isosorbids und ihre Verwendung
EP0875240A2 (fr) Combinaisons ou complèxes de dérivés du dibenzoyméthane et/ou de dérivés de l&#39;acide cinnamique avec des cyclodextrines et utilisation des combinaisons dans des compositions cosmétiques de protection solaire
EP1916990B1 (fr) Combinaisons d&#39;agents actifs stables a base d&#39;acide folique
WO2005025521A2 (fr) Preparations pulverulentes contenant un melange de 2,4,6-trianilino-p-(carbo-2&#39;-ethylhexyl-1&#39;-oxi)-1,3,5-triazine et de diethylamino-hydroxybenzoyl-hexyl-benzoate
DE19739349A1 (de) Verwendung von Troxerutin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
EP0826360A2 (fr) Utilisation des dérivés de dibenzoylmethane pour atteindre ou améliorer la solubilité des dérivés de triazine dans l&#39;huile
DE19651055B4 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Dimethylisosorbid und deren Verwendung
DE19962267A1 (de) Verwendung von Wirkstoffkombinationen aus einem oder mehreren NO-Synthasehemmern und einer oder mehreren Ascorbylverbindungen zur Stärkung der Barrierefunktion der Haut
EP0995429A1 (fr) Utilisation de silicones comme tensioactifs ainsi que d&#39;autres agents tensioactifs pour augmenter le facteur photoprotectif et/ou la protection contre les UV-A des compositions cosmétiques ou dermatologiques photoprotectrices
DE19710854C2 (de) Verwendung von Benzophenonen und deren Derivaten gegen die UV-induzierte Zersetzung von Dibenzoylmethan und dessen Derivaten
EP0895775B1 (fr) Compositions photoprotectives contenants des pigments inorganiques enrobées sur leurs surfaces avec des filtres UV

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BG BR BY CA CN CZ DZ HU ID IL IN JP KR MX NO NZ PL RO RU SG SI SK UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP